Short answer · Medically reviewed summary · Last updated: 2026-04-06
Psoriasis has been recognized for millennia, with early historical descriptions dating back to ancient civilizations, though it was frequently conflated with leprosy until the 19th century. Ancient Roots and Early Misconceptions The history of Psoriasis is deeply intertwined with human history, as descriptions of "scaly" skin conditions appear in the Ebers Papyrus of ancient Egypt and the Hippocratic writings of ancient Greece. For centuries, the disease was often confused with leprosy, leading to significant social stigma and isolation for those affected.
1 people with Psoriasis have shared their first-person experience on this question at DiseaseMaps.
What is the history of Psoriasis?
History of Psoriasis: when and how it was discovered, and the milestones in research since, medically reviewed.
Psoriasis has been recognized for millennia, with early historical descriptions dating back to ancient civilizations, though it was frequently conflated with leprosy until the 19th century.
Ancient Roots and Early Misconceptions
The history of Psoriasis is deeply intertwined with human history, as descriptions of "scaly" skin conditions appear in the Ebers Papyrus of ancient Egypt and the Hippocratic writings of ancient Greece. For centuries, the disease was often confused with leprosy, leading to significant social stigma and isolation for those affected. It was not until the late 18th and early 19th centuries that medical pioneers, specifically Robert Willan and Thomas Bateman, began to differentiate Psoriasis from other dermatological conditions, establishing it as a distinct clinical entity.
Evolution of Understanding and Treatment
In the 20th century, the medical community’s understanding of the condition underwent a paradigm shift. Once viewed merely as a localized skin ailment, Psoriasis is now recognized as a complex, chronic, systemic immune-mediated disease. This shift was fueled by the discovery of the role of T-cells and inflammatory cytokines, such as TNF-alpha and interleukins, in the pathogenesis of the condition.
Major milestones in treatment have evolved from crude topical applications—such as coal tar and crude sunlight exposure—to highly targeted therapies:
- Phototherapy: The application of UV light, which remains a cornerstone of treatment.
- Systemic agents: The introduction of methotrexate and cyclosporine in the mid-20th century.
- Biologics: The 21st-century revolution involving monoclonal antibodies that target specific pathways, offering life-changing relief for many patients.
The Modern Era
Today, advancements in genomics have identified numerous susceptibility loci, helping researchers understand why Psoriasis runs in families and how the immune system triggers hyper-proliferation of skin cells. Patient advocacy groups have been instrumental in transforming the narrative of Psoriasis from a "cosmetic" issue to a serious health condition, demanding more research funding and improved quality-of-life standards for patients worldwide.
Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)
- National Psoriasis Foundation (NPF)
- Online Mendelian Inheritance in Man (OMIM)
Posted Sep 25, 2017 by Omar martin 2000
